Search Within

Heiko Schoder

  1. "Laure Michaud"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (14)
  3. Book Section (1)
Groups
  1. Molecular Imaging and Therapy Service (29)
  2. Radiology, Department of (29)
  3. Sloan Kettering Institute Postdocs (29)
  4. Department of Medicine (23)
  5. Hematologic Malignancies, Division of (19)
  6. Center for Hematologic Malignancies (18)

More Groups

People
  1. Laure Michaud (29)
  2. Reiko Nakajima (12)
  3. Audrey Mauguen (11)
  4. Connie Batlevi (10)
  5. Gilles Salles (10)
  6. Alison Moskowitz (9)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (7)

More Years

Publications
  1. Journal of Nuclear Medicine (8)
  2. Blood (6)
  3. European Journal of Nuclear Medicine and Molecular Imaging (3)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Blood Advances (1)
  6. Cancers (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (8)
  2. American Society of Hematology (7)
  3. Springer (4)
  4. Elsevier Inc. (3)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Development and validation of diagnostic interpretation criteria for evaluation of F-18 Fluoromisonidazole hypoxia PET/CT – Inter-reader reliability and accuracy
    Meeting Abstract

    Wray, R.; Mauguen, A.; Michaud, L.; Leithner, D.; Sherman, E.; Riaz, N.; Humm, J.; Mirtcheva, R.; Boyle, J. O.; Wong, R. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade
    Meeting Abstract

    Wills, B.; Michaud, L.; Schöder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • End of therapy (18)F-FDG PET/CT for assessment of persistent bone involvement in B-cell lymphoma
    Meeting Abstract

    Michaud, L.; Nakajima, R.; Joffe, E.; Ghione, P.; Ahsanuddin, S.; Navitski, A.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Journal Article

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Mauguen, A.; Elko, T. A.; Ruiz, J. D.; Maloy, M. A.; Sauter, C. S.; Dahi, P. B.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • (11)C-choline PET/CT in recurrent prostate cancer: Retrospective analysis in a large U.S. patient series
    Journal Article

    Michaud, L.; Touijer, K. A.; Mauguen, A.; Zelefsky, M. J.; Morris, M. J.; Lyashschenko, S. K.; Durack, J. C.; Humm, J. L.; Weber, W. A.; Schöder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save